⌘K

Login Start Free

Home/Insiders/Pamukcu Rifat

PR

SEC Insider//CIK 0001929298

Pamukcu Rifat

CIK 00019292981 companyDOYLESTOWN, PA

Transactions

12

Companies

1

Filings

4

CIK

0001929298

Recent Transactions

12 trades

Award
Aprea Therapeutics, Inc.$APRE
Stock Options (Right to Buy)
2025-06-05+4,185→ 4,185 total
Award
Aprea Therapeutics, Inc.$APRE
Common Stock
2025-06-05+1,045→ 5,446 total
Award
Aprea Therapeutics, Inc.$APRE
Common Stock
2024-06-20+1,045→ 4,401 total
Award
Aprea Therapeutics, Inc.$APRE
Stock Options (Right to Buy)
2024-06-20+4,185→ 4,185 total
Award
Aprea Therapeutics, Inc.$APRE
Stock Options (Right to Buy)
2023-08-23+2,000→ 2,000 total
Award
Aprea Therapeutics, Inc.$APRE
Common Stock
2023-08-23+500→ 3,356 total
Conversion
Aprea Therapeutics, Inc.$APRE
Series A Non-Voting Convertible Preferred Stock
2022-08-23−4,928→ 0 total
Conversion
Aprea Therapeutics, Inc.$APRE
Common Stock
2022-08-23+49,280→ 57,142 total
Conversion
Aprea Therapeutics, Inc.$APRE
Common Stock
2022-08-23+271,870→ 14,108 total
Conversion
Aprea Therapeutics, Inc.$APRE
Series A Non-Voting Convertible Preferred Stock
2022-08-23−27,187→ 0 total
Award
Aprea Therapeutics, Inc.$APRE
Stock Option (right to Buy)
2022-07-28+29,575→ 29,575 total
Award
Aprea Therapeutics, Inc.$APRE
Common Stock
2022-07-28+5,995→ 7,862 total

Companies

1

Aprea Therapeutics, Inc.
Director
$APRE

Recent Filings

4

Address

3805 OLD EASTON ROAD

DOYLESTOWN, PA, 18902

View on SEC.gov